XML 33 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Shareholder's Equity (Deficit) - USD ($)
$ in Thousands
Temporary Equity [Member]
Preferred A Shares Microbot Medical Ltd. Pre-Merger [Member]
 [1]
Preferred A Shares Microbot Medical Ltd. Post-Merger [Member]
 [1]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2014 $ 87 $ 132 $ 3,089 $ (2,451) $ 857
Balance, shares at Dec. 31, 2014   8,708,132 13,182,660      
Transaction costs incurred in reverse recapitalization            
Net loss (921) (921)
Balance at Dec. 31, 2015 $ 87 $ 132 3,089 (3,372) (64) [2]
Balance, shares at Dec. 31, 2015   8,708,132 13,182,660      
Conversion of convertible notes and exercise of warrants issued upon conversion $ 48 1,803 1,851
Conversion of convertible notes and exercise of warrants issued upon conversion, shares   4,746,237      
Effect of reverse recapitalization $ (135) $ 153 454 472
Effect of reverse recapitalization, shares   (13,454,369) 15,301,675      
Common Stock classified as temporary equity 500 (500) (500)
Beneficial Conversion Feature recorded on convertible debt acquired in reverse recapitalization 2,029 2,029
Transaction costs incurred in reverse recapitalization $ 78 6,817 (347)
Transaction costs incurred in reverse recapitalization, shares   7,802,639      
Cancellation of ordinary shares and issuance of preferred shares $ (97) 97
Cancellation of ordinary shares and issuance of preferred shares, shares   9,736 (9,736,000)      
Share based compensation 676 676
Net loss   (9,663) (9,663)
Balance at Dec. 31, 2016 $ 500 $ 266 $ 14,465 $ (13,035) $ 1,696 [2]
Balance, shares at Dec. 31, 2016   9,736 26,550,974 [3]      
[1] Share data for periods prior to the reverse recapitalization represents the legal equity structure of Microbot Medical Ltd. with the number of shares adjusted to retroactively reflect the one-to-nine Reverse Stock Split effected on November 28, 2016 as well as the reverse recapitalization consummated on November 28, 2016
[2] December 31 2015 share data represents the legal equity structure of Microbot Medical Ltd. with the number of shares adjusted to retroactively reflect the one-to-nine Reverse Stock Split effected on November 28, 2016 as well as the reverse recapitalization consummated on November 28 2016.
[3] Includes 10,702,838 shares of common stock classified as temporary equity.